191 related articles for article (PubMed ID: 20140704)
1. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer.
Hirche C; Murawa D; Mohr Z; Kneif S; Hünerbein M
Breast Cancer Res Treat; 2010 Jun; 121(2):373-8. PubMed ID: 20140704
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
[TBL] [Abstract][Full Text] [Related]
3. Use of Fluorescence Imaging in Combination with Patent Blue Dye versus Patent Blue Dye Alone in Sentinel Lymph Node Biopsy in Breast Cancer.
Tong M; Guo W; Gao W
J Breast Cancer; 2014 Sep; 17(3):250-5. PubMed ID: 25320623
[TBL] [Abstract][Full Text] [Related]
4. ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial.
Grischke EM; Röhm C; Hahn M; Helms G; Brucker S; Wallwiener D
Geburtshilfe Frauenheilkd; 2015 Sep; 75(9):935-940. PubMed ID: 26500370
[No Abstract] [Full Text] [Related]
5. Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
Lee EG; Lee DE; Jung SY; Han JH; Kim SK; Chae H; Sim SH; Lee KS; Lee S
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38717546
[TBL] [Abstract][Full Text] [Related]
6. In vivo quantitative evaluation of the transport kinetics of gold nanocages in a lymphatic system by noninvasive photoacoustic tomography.
Cai X; Li W; Kim CH; Yuan Y; Wang LV; Xia Y
ACS Nano; 2011 Dec; 5(12):9658-67. PubMed ID: 22054348
[TBL] [Abstract][Full Text] [Related]
7. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer.
Wishart GC; Loh SW; Jones L; Benson JR
Eur J Surg Oncol; 2012 Aug; 38(8):651-6. PubMed ID: 22704050
[TBL] [Abstract][Full Text] [Related]
8. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer.
Pitsinis V; Provenzano E; Kaklamanis L; Wishart GC; Benson JR
Surg Oncol; 2015 Dec; 24(4):375-9. PubMed ID: 26555151
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience.
Verbeek FP; Troyan SL; Mieog JS; Liefers GJ; Moffitt LA; Rosenberg M; Hirshfield-Bartek J; Gioux S; van de Velde CJ; Vahrmeijer AL; Frangioni JV
Breast Cancer Res Treat; 2014 Jan; 143(2):333-42. PubMed ID: 24337507
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green fluorescence-guided sentinel node biopsy: a meta-analysis on detection rate and diagnostic performance.
Xiong L; Gazyakan E; Yang W; Engel H; Hünerbein M; Kneser U; Hirche C
Eur J Surg Oncol; 2014 Jul; 40(7):843-9. PubMed ID: 24613744
[TBL] [Abstract][Full Text] [Related]
11. Indocyanine green detects sentinel lymph nodes in early breast cancer.
Liu J; Huang L; Wang N; Chen P
J Int Med Res; 2017 Apr; 45(2):514-524. PubMed ID: 28415938
[TBL] [Abstract][Full Text] [Related]
12. Network meta-analysis of novel and conventional sentinel lymph node biopsy techniques in breast cancer.
Mok CW; Tan SM; Zheng Q; Shi L
BJS Open; 2019 Aug; 3(4):445-452. PubMed ID: 31388636
[TBL] [Abstract][Full Text] [Related]
13. Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial.
Valente SA; Al-Hilli Z; Radford DM; Yanda C; Tu C; Grobmyer SR
J Am Coll Surg; 2019 Apr; 228(4):672-678. PubMed ID: 30582975
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer.
Lin J; Lin LS; Chen DR; Lin KJ; Wang YF; Chang YJ
Asian J Surg; 2020 Dec; 43(12):1149-1153. PubMed ID: 32143963
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery.
Kedrzycki MS; Leiloglou M; Ashrafian H; Jiwa N; Thiruchelvam PTR; Elson DS; Leff DR
Ann Surg Oncol; 2021 Jul; 28(7):3738-3748. PubMed ID: 33156466
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison between indocyanine green fluorescence plus
Vermersch C; Raia-Barjat T; Chapelle C; Lima S; Chauleur C
Sci Rep; 2019 May; 9(1):6943. PubMed ID: 31061432
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of ICG-fluorescence with conventional tracers in sentinel lymph node biopsy for patients with early-stage breast cancer: A meta-analysis.
Yin R; Ding LY; Wei QZ; Zhou Y; Tang GY; Zhu X
Oncol Lett; 2021 Feb; 21(2):114. PubMed ID: 33376546
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer.
Agrawal SK; Hashlamoun I; Karki B; Sharma A; Arun I; Ahmed R
JCO Glob Oncol; 2020 Jul; 6():1225-1231. PubMed ID: 32749861
[TBL] [Abstract][Full Text] [Related]
19. Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: systematic review and meta-analysis.
Goonawardena J; Yong C; Law M
Am J Surg; 2020 Sep; 220(3):665-676. PubMed ID: 32115177
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of indocyanine green combined with blue dye with methylene blue only and carbon nanoparticles only for sentinel lymph node biopsy in breast cancer.
Qin X; Yang M; Zheng X
Ann Surg Treat Res; 2019 Jul; 97(1):1-6. PubMed ID: 31297346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
